PINK1 and osteosarcoma: To assess the response of each candidate reporter, each PINK1-SPARK prototype was expressed in U2OS osteosarcoma cells and treated with carbonyl cyanide m-chlorophenylhydrazone (CCCP), an uncoupler of oxidative phosphorylation.